Summary of the Undertaking given by Dr. Dr. David Low Kyle Ballingall to the College of Physicians and Surgeons of Ontario, effective June 25, 2020:

A College investigation was conducted into whether Dr. Ballingall engaged in professional misconduct and/or am incompetent in my walk-in practice. As a result of the investigation:

Dr. Ballingall is limited to practicing as a general practitioner in the Oncology Clinic at London Health Sciences Centre Oncology Clinic and must practice no more than one (1) day per week.

Dr. Ballingall must not issue new prescriptions or renew existing prescriptions for or administer any of the following substances:

(i) Narcotic Drugs (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);
(ii) Narcotic Preparations (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);
(iii) Controlled Drugs (from Part G of the Food and Drug Regulations under the Food and Drugs Act, S.C., 1985, c. F-27);
(iv) Benzodiazepines and Other Targeted Substances (from the Benzodiazepines and Other Targeted Substances Regulations made under the Controlled Drugs and Substances Act., S.C., 1996, c. 19);
(v) Monitored Drugs (as defined under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22);
and as amended from time to time.

In addition, Dr. Ballingall will undergo a reassessment of his practice in approximately 6 months.